Nuclear Medicine Physics

                                         
Dr.Kattesh V. Katti will be participating at the International Conference on Atomic & nuclear Physics held by Scientific Federation Professor Kattesh V. Katti is invited as plenary Speaker for this conference. Globally recognized as the ‘Father of Green Nanotechnology’, Professor Kattesh V. Katti, MSc Ed, PhD, DSc, FRSC, FNAI, Curators’ Professor of Radiology, Director, Institute of Green Nanotechnology, within the Medical School, University of Missouri, Columbia, USA is internationally renowned as a leader in the interconnecting fields of chemistry, radiopharmaceutical sciences, nanotechnology/green nanotechnology and nanomedicine for biomedical applications, specifically for molecular imaging and therapy of living subjects. Dr. Katti has been awarded a number of international awards and citations, which include: Winner of the 2016 'Person of the Year in Science' award. Dr. Katti was selected for this coveted award for his pioneering research in Green Nanotechnology with applications to Nanomedicine and Oncology. Dr. Katti has won the International Hevesy Medal Award (2015) A Global award for excellence in Nuclear Sciences/Nuclear Medicine for his life time contributions in SPECT/CT Imaging, Radiotherapy through radioactive gold nanoparticles; Elected to the fellowship of the National Academy of Inventors (2015) recognizing the discovery of ‘Katti Peptides’ a group of peptides used in biomedical sciences and nanomedicine research. In recognitions of his groundbreaking discoveries of radioactive gold nanoparticles in cancer therapy with implications in theranostics and plethora of original research in SPECT imaging, Dr. Katti has been recognized as One of the ‘25 Most Influential Scientists In Molecular Imaging in the World’ by RT Image. Dr. Katti has received the ‘Father of Green Nanotechnology’ citation by the Nobel Prize Winner Norman Borlaug, and has been bestowed with the Gauss Professorship Hall of Fame From the Gottingen Academy of Sciences.

Professor Kattesh V. Katti is going to talk on Radioactive Gold-198 Nanoparticles In Nanomedicine: Green Nanotechnology and Radiochemical Approaches in Oncology Cancer alone continues to kill more people than AIDS, malaria, and tuberculosis combined. According to the International Agency for Research on Cancer, there were 12.7 million new cancer cases in 2008. The World Health Organization projects that without major breakthroughs in cancer prevention, discovery of new and accurate diagnostic modalities and development of highly effective therapeutic approaches, the global number of deaths from cancer will increase by nearly 80% by 2030, with most occurring in low- and middle-income countries. There are over 100 pharmaceutical formulations approved by the US Food and Drug Administration (FDA) in order to combat this deadly pandemic. Although surgery and radiation treatments are the initial treatments for most cancers, a large number of oncological approaches are being used to control or cure cancer. Today cancer patients have more choices in which treatment or combination of treatments may be used encompassing three areas of emphasis: (a) Chemotherapy, (b) Hormone therapy; (c) Biological treatment. Despite the currently available choice of established anticancer agents for first-line of activity against cancer, effective delivery of chemotherapeutic, hormonal and biological pharmaceuticals to the tumor tissue and cancer cells selectively continues to be the most vexing problems in cancer oncology. Problems associated with effective delivery of cancer drugs pose severe oncological challenges especially when treating solid tumors (sarcomas, carcinomas, and lymphomas) which account for over 85% of all human cancers. Circumventing these problems is not easy because molecular and cellular biology of neoplastic cells alone has failed to explain the non-uniform uptake of these agents in solid tumors. Repeated delivery of cancer drugs leads to systemic toxicity creating major collateral adverse effects where cancer cells mutate making them resistant to chemotherapeutic treatments. Therefore, the discovery of new drug delivery approaches that effectively penetrate extracellular compartments consisting of vascular and interstitial valves within solid tumors is of profound importance.

ICANP-2018 brings along leading scientists, engineers, administrators of firms within the scope of Atomic & physics to exchange data on their current analysis progress. ICANP-2018 has initiated with an excellent Organizing Committee from well-known universities across the world, creating it a specially designed cluster conference which will be covering most aspects and fields of Atomic & physics.

URL- http://scientificfederation.com/atomic-nuclear-physics-2018/